Teva drops 16% after states accuse drugmaker of conspiring to hike generic drug prices

Forty-four U.S. states, led Connecticut Attorney General William Tong, claim 20 drug companies, including Teva, "systematically" divided up the market for generic drugs to avoid competing with one another.